Total Funding
39
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
165721
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Acquired by 
Alexion Pharmaceuticals
- Leszek Lisowski: co-founder
Adi Barzel: Founder
About the Company
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non-pathogenic adeno-associated viral vector offers superior efficiency and safety compared to all competitors on the
market and is uniquely suited for the treatment of children as well as adults.
